Omicron
Study Explains Why Omicron Variants Continue To Spread
Dr Jitendra Launches The GEMCOVAC®—OM, An Omicron-Specific mRNA-Based Booster Vaccine
Omicron-Specific mRNA-Based Booster Vaccine Developed Using The Indigenous Platform Technology
Over 1,300 samples of Omicron sub-variant XBB2.3 found in India, XBB.1.16 dominant in country: INSACOG
XBB.1.16 is now a Covid ‘variant of interest’: WHO
India sees surge in Covid cases; virus moving towards endemic stage, say officials
Omicron XBB.1.16 Is 'One To Watch': WHO
Those Infected In 1st Covid Wave Were 40% Less Likely To Get Omicron
Lower Omicron Death Rate Behind Poor Intake Of Booster Shots: Expert
New Omicron Subvariant Resistant To All Antibody Therapies: Indian-Origin Scientist
Scientists Identify Ultra-Potent Antibody That Can Offset All Omicron Variants
mRNA Vaccines Significantly Cut Severity Of Delta, Omicron Infections
Study Provides Insight Into Potential Animal Reservoir Of SARS-CoV-2 Omicron
Russia Develops Delta & Omicron-Adapted Sputnik V Vaccine
Reinfection With Omicron More Common Than Thought: Study
Iran tightens entry rules amid increasing Covid-19 cases